Key Points
- The CDMRP recently listed several funding opportunities that may be of interest to the focused ultrasound community.
- Up to $9 million is available for Parkinson’s research, and more than $1 million is available for rare cancer research in three grant programs.
The Congressionally Directed Medical Research Programs (CDMRP) has listed several funding opportunities that may be
relevant to the focused ultrasound community.
The CDMRP is affiliated with the US Department of Defense and fosters novel approaches to biomedical research in response to the expressed needs of its stakeholders-the American public, the military, and Congress. The CDMRP fills research gaps by funding high impact, high risk, and high gain projects that will lead to cures or improvements in patient care, or breakthrough technologies and resources for clinical benefit. Since it was established in 1992, the CDMRP has managed Congressional appropriations totaling $17.8 Billion.
Information regarding current funding opportunities for Parkinson’s disease and cancer is below.
Parkinson’s Disease
Pre-Announcement: Department of Defense Parkinson’s Research Program (PRP)
Applications must address one or more of the following focus areas:
– Biological mechanisms and biomarkers of non-motor symptoms that could lead to the development of treatments for Parkinson’s disease (PD). Examples of non-motor symptoms of interest: cognitive dysfunction relevant to PD, psychiatric dysfunction, sleep and circadian rhythms disruptions, autonomic dysfunction, sensory dysfunction, and fatigue.
– Biological mechanisms and biomarkers of non-pharmacological interventions for non-motor symptoms in PD, such as exercise, diet, neuro stimulation therapy, and neurosurgical.
Funding: Up to $9 million, for up to 4 years, dependent upon award mechanism
LEARN MORE >
Cancer
FY22 Rare Cancers, Concept Award
The FY22 RCRP Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. The Concept Award is not intended to support an incremental progression of an already established research project; instead, it allows Principal Investigators (PIs) the opportunity to pursue serendipitous observations.
Funding: Up to $100,000, for 1 year
Deadline: Pre-Application: 7/18/22 | Proposal: 8/29/22
Opportunity Number: W81XWH-22-RCRP-CA
LEARN MORE >
FY22 Rare Cancers, Idea Development Award
The FY22 RCRP Idea Development Award promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from rare cancers. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.
Funding: Up to $350,000, for up to 3 years
Deadline: Pre-Application: 6/22/22 | Invited application: 9/30/22
Opportunity Number: W81XWH-22-RCRP-IDA
LEARN MORE >
FY22 Rare Cancers, Resource and Community Development Award
The FY22 RCRP Resource and Community Development Award supports the development of resources that advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Major gaps in patient care of rare cancers include lack of communication and dissemination strategies for rare cancer research and clinical findings within communities; lack of therapeutics and mechanistic studies to inform treatment development; lack of research and clinical resources, including patient tissues, cell, and tumor models; and lack of infrastructure for sharing data and other resources.
Funding: Up to $600,000, for up to 3 years
Deadline: Pre-Application: 6/22/22 | Invited application: 9/30/22
Opportunity Number: W81XWH-22-RCRP-RCDA
LEARN MORE >